Philippines Health News API

{
    "totalArticles": 109836,
    "articles": [
        {
            "id": "4095824f883fe405d420f1c09f001d35",
            "title": "Countdown Grant Explores How Cells Remove Damaged Mitochondria - Opening New Possibilities Across Parkinson’s, Chronic Disease, Rare Disease, and Aging",
            "description": "ATLANTA, May 15, 2026 (GLOBE NEWSWIRE) -- Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.",
            "content": "ATLANTA, May 15, 2026 (GLOBE NEWSWIRE) -- Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research Institute of M... [8236 chars]",
            "url": "https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/countdown-grant-explores-how-cells-remove-damaged-mitochondria-opening-new-possibilities-across-parkinsons-chronic-disease-rare-disease-and-aging/2345260",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/16/1059399.png",
            "publishedAt": "2026-05-15T19:26:31Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "4e20f7762b29d70d873ac07bdd7c726e",
            "title": "Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer",
            "description": "A Phase II trial finds that sacituzumab govitecan produced durable responses in heavily pretreated recurrent uterine cancer patients.",
            "content": "A Phase II clinical trial led by researchers at Yale School of Medicine and Yale Cancer Center has found that the antibody-drug conjugate sacituzumab govitecan, also known as Trodelvy, demonstrated encouraging clinical activity in patients with recur... [5059 chars]",
            "url": "https://www.insideprecisionmedicine.com/topics/oncology/antibody-drug-conjugate-shows-activity-in-hard-to-treat-uterine-cancer/",
            "image": "https://www.insideprecisionmedicine.com/wp-content/uploads/2020/02/Endometrial-843358252-e1756321381912.jpg",
            "publishedAt": "2026-05-15T19:12:45Z",
            "lang": "en",
            "source": {
                "id": "109f786697844947c1fdd219350f1b78",
                "name": "Inside Precision Medicine",
                "url": "https://www.insideprecisionmedicine.com"
            }
        },
        {
            "id": "f42f4351123970f0e7b71bda157c238a",
            "title": "PCOS Is Now PMOS: What The New Name Means For The Women It Affects",
            "description": "PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition",
            "content": "For nearly a decade, millions of women have been diagnosed with a condition called Polycystic Ovary Syndrome – a name that limited both timely diagnosis and treatment. This month, the medical community and affected patient population corrected the mi... [4320 chars]",
            "url": "https://www.forbes.com/sites/adairalandry/2026/05/15/pcos-is-now-pmos-what-the-new-name-means-for-the-women-it-affects/",
            "image": "https://imageio.forbes.com/specials-images/imageserve/6a07361550427f71ae2c6ebc/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "publishedAt": "2026-05-15T17:26:16Z",
            "lang": "en",
            "source": {
                "id": "c4e32b557a3dd75225975f11fb68a3a9",
                "name": "Forbes",
                "url": "https://www.forbes.com"
            }
        }
    ]
}